GYULA GAL


I was born and raised in Hungary. Graduated at the Medical University of Szeged, Hungary1980. Three years later, I left Hungary due to political reasons, and spent the last 38 years of my life in Scandinavia. I'm authorised MD in Hungary, Sweden and Denmark, board certified radiologist since 1991 and neuroradiologist since 1993.

Started my neurointerventional training 1995, in Gothenburg, Sweden, continued in Oxford and Paris. Have been working mainly with interventional neuroradiology since 1995, first at the University Hospital in Uppsala, Sweden, as senior consultant, from 1996 until 2007, then a short period at the University Hospital in Wuerzburg, Germany, and from 2008 until now at the Odense University Hospital, Denmark.

In my clinical practice, I've been treating annually 150 intracranial aneurysms, 20 AVMs, 15 DAVFs, and performing 10 preoperative embolisations of intracranial and head and neck tumors. I have extensive experience with flow diverters, like the SILK, PED, FRED and Surpass, liquid embolic agents, like the Onyx, since 1999, and the SQUID, since its introduction, performing the first human brain AVM treatment with that December 2011.

I'm an experienced strokeINR with many years of experience with both the thromboaspiration, mechanical thrombectomy and the combination of these. I have worked with every generation of the Penumbra devices. I performed the first ACE64 case worldwide and the first ACE68 case in Europe. I have been active in all relevant stroke societies in Europe and presented at numerous conventions. At my previous workplace, the University Hospital in Uppsala, Sweden, I participated in the ISAT study, between 1996-2007 (International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial, documented in several scientific papers, published in the Lancet, from 2002). In the Odense University Hospital, I annually perform >100 mechanical thrombectomies in the management of patients with acute ischemic stroke.

I've been member of the Swedish, Hungarian and Nordic Societies of Neuroradiology since 1993, senior member of the World Federation of Interventional and Therapeutic Neuroradiology since 1997, and the International Andreas Gruentzig Society since 2004, where I served as member of the Board of Directors. I've been participating in every biannual meeting of these societies, starting 1997, in all annual meetings of the Working Group of Interventional Neuroradiology (WIN) since 1995, the European Society of Minimally Invasive Neurological Therapy (ESMINT) since 2009, and the World Live Neurovascular Conference since 2013, as invited speaker/faculty.